RAPAMUNE*30CPR RIV 2MG

( DrugBank: - / KEGG DRUG: - )

1 disease

告示番号	疾患名（ページ内リンク）	臨床試験数
67	多発性嚢胞腎	2

67. 多発性嚢胞腎

臨床試験数 : 221 / 薬物数 : 212 - (DrugBank : 55) / 標的遺伝子数 : 40 - 標的パスウェイ数 : 151

trials per page:

Showing 1 to 2 of 2 trials

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	EUCTR2007-005047-21-IT (EUCTR)	24/12/2007	02/07/2008	Effects of Sirolimus on disease progression in patients with Autosomal Dominant Polycystic Kidney Di ...	Effects of Sirolimus on disease progression in patients with Autosomal Dominant Polycystic Kidney Di ...	Autosomal Dominant Polycystic Kidney Disease (ADPKD) MedDRA version: 9.1;Level: LLT;Classification c ...	Trade Name: RAPAMUNE100CPR RIV1MG INN or Proposed INN: Sirolimus Trade Name: RAPAMUNE30CPR RIV 2MG IN ...	IST. DI RICERCHE FARMACOLOG. M. NEGRI	NULL	Not Recruiting			Female: yes Male: yes	40	Phase 2	Italy
2	EUCTR2006-003427-37-IT (EUCTR)	05/02/2007	27/12/2006	Sirolimus treatment in patients with autosomal dominant polycystic kidney disease renal efficacy and ...	Sirolimus treatment in patients with autosomal dominant polycystic kidney disease renal efficacy and ...	Autosomal-Dominant Polycystic Kidney Disease ADPKD MedDRA version: 9.1;Level: LLT;Classification cod ...	Trade Name: RAPAMUNE30CPR RIV1MG INN or Proposed INN: Sirolimus Trade Name: RAPAMUNE30CPR RIV 2MG INN ...	IST. DI RICERCHE FARMACOLOG. M. NEGRI	NULL	Not Recruiting			Female: yes Male: yes	16	Phase 2	Italy

First Previous1Next Last